Article
High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.
Haematologica - 1 Jan 2014
Cario Gunnar, Rhein Peter, Mitlöhner Rita, Zimmermann Martin, Bandapalli Obul R, Romey Renja, Moericke Anja, Ludwig Wolf-Dieter, Ratei Richard, Muckenthaler Martina U, Kulozik Andreas E, Schrappe Martin, Stanulla Martin, Karawajew Leonid
Abstract excerpt
Further improvement of outcome in childhood acute lymphoblastic leukemia could be achieved by identifying additional high-risk patients who may benefit from intensified treatment. We earlier identified PTPRC (CD45) gene expression as a potential new stratification marker and now analyzed the prog...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.